ELEUSIS
Eleusis is a clinical stage life science company dedicated to unlocking the therapeutic potential of serotonin 2A receptor agonists, commonly referred to as psychedelics, through the mitigation and management of psychoactivity
ELEUSIS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2013-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.eleusisltd.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.74 M USD
Technology used in webpage:
SPF Google Apps For Business Unified Layer BlueHost BlueHost DNS
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Aprea
Aprea is a biopharmaceutical company that develops novel cancer therapeutics.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Employees Featured
Founder
Investors List
Palo Santo Fund
Palo Santo Fund investment in Series A - Eleusis
Official Site Inspections
http://www.eleusisltd.com Semrush global rank: 2.55 M Semrush visits lastest month: 6.91 K
- Host name: 217-160-0-80.elastic-ssl.ui-r.com
- IP address: 217.160.0.80
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Eleusis"
Eleusis - Crunchbase Company Profile & Funding
Contact Email [email protected] Eleusis is a clinical stage life science company dedicated to unlocking the therapeutic potential of serotonin 2A receptor agonists, commonly referred to as psychedelics, through the …See details»
Eleusis - Overview, News & Similar companies | ZoomInfo.com
Eleusis contact info: Phone number: (646) 290-5700 Website: www.eleusisltd.com What does Eleusis do? Founded in 2013, Eleusis is a privately held, clinical-stage life science company …See details»
Eleusis Company Overview, Contact Details & Competitors | LeadIQ
Eleusis. Biotechnology Research England, United Kingdom 11-50 Employees. Founded in 2013, Eleusis is a clinical-stage life science company dedicated to unlocking the full therapeutic …See details»
Eleusis - LinkedIn
Eleusis | 4,349 followers on LinkedIn. Transforming Psychedelics into Medicines | Founded in 2013, Eleusis is a clinical-stage life science company dedicated to unlocking the full …See details»
Disclaimer - Eleusis
If you have any concerns relating to the privacy or confidentiality of this website, please contact Eleusis’s Data Protection Officer [email protected]. Eleusis is a life science company …See details»
Eleusis Benefit Corporation - Psychedelic Science Review
Organization Information. Founded: 2013: Notable Employees: Charles D. Nichols: Shlomi Raz: Twitter @EleusisLtd: LinkedIn: Eleusis Benefit Corporation: Website: Eleusis Benefit …See details»
Beckley Psytech strengthens pipeline and development team with ...
Oct 21, 2022 Eleusis Therapeutics Limited – www.eleusisltd.com. Founded in 2013, Eleusis is a clinical-stage life science company that aims to unlock the therapeutic potential of …See details»
Eleusis Overview | SignalHire Company Profile
Founded in 2013, Eleusis is a clinical-stage life science company dedicated to unlocking the full therapeutic potential of psychedelics, guided by science and enabled by drug discovery, …See details»
Eleusis - LinkedIn
Eleusis | 4,288 followers on LinkedIn. Transforming Psychedelics into Medicines | Founded in 2013, Eleusis is a clinical-stage life science company dedicated to unlocking the full …See details»
Eleusis Company Profile - Office Locations, Competitors ... - Craft
Eleusis has 5 employees across 3 locations. See insights on Eleusis including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Eleusis - Company Profile & Staff Directory - ContactOut
Founded in 2013, Eleusis is a clinical-stage life science company dedicated to unlocking the full therapeutic potential of psychedelics, guided by science and enabled by drug discovery, …See details»
Eleusis Company Profile 2024: Valuation, Funding & Investors
Eleusis General Information Description. Developer of psychedelic drug therapies intended to address unmet needs within and beyond psychiatry. The company's pipeline features a novel …See details»
Eleusis | Transforming Psychedelics into Medicines - eleusisltd.com
Enabling convenient and affordable access to the therapeutic potential of psychedelics requires care delivery innovation. Andala, an Eleusis subsidiary, and affiliated physician practices, are …See details»
Psychedelic Science Leader Eleusis Announces Four New Board ...
Jul 12, 2021 Email: [email protected]. Media: Dan Gagnier / Jeffrey Mathews Tel: 646-569-5897 Email: [email protected]. Eleusis is a life science company based in …See details»
Eleusis Therapeutics US - Buzzfile
Www.eleusisltd.com: There are 136 Companies located at 222 BROADWAY, New York, NY 10038 Map View larger ... This organization primarily operates in the Pharmaceutical …See details»
Psychedelic Science Leader Eleusis to Become Public Company in …
Jan 21, 2022 Eleusis, a clinical-stage life science company that aims to unlock the therapeutic potential of psychedelics, and Silver Spike Acquisition Corp. II (NASDAQ: SPKB) a publicly …See details»
Eleusis Securities Marketing Statement | Eleusis - eleusisltd.com
London. 6th Floor 25 Farringdon Street London, United Kingdom, EC4A 4ABSee details»
Psychedelic Science Leader Eleusis Announces Four New Board ...
Jul 12, 2021 Eleusis Inquiries: Alex Speiser Email: [email protected] Media: Dan Gagnier / Jeffrey Mathews Tel: 646-569-5897 Email: [email protected] Release …See details»
Eleusis Announces the Appointment of David Guyer, M.D., to …
Eleusis, a clinical stage life science company established to develop the therapeutic potential of serotonin 2A receptor (5-HT 2A) agonists, also known as psychedelics, today announced the …See details»
Eleusis Presents New Research on the Anti-Inflammatory Potential …
Oct 23, 2019 Eleusis, a clinical stage life science company established to develop the therapeutic potential of serotonin 2A receptor (5-HT 2A) agonists, also known as psychedelics, …See details»